Pluspunten
The overall corporate (global) portion of the company has a lot of money which masks a lot of issues at site level. MSD has a good reputation in ireland in most other sites than here.
Minpunten
The Dunboyne site has been completely miss-managed by the SLT & HR from the Takeda days - through covid - and up until relatively recently. There has been a small improvement after former SLT were "quiet-Fired" and rotated to irrelevant positions. American legacy directors have arrived to replace the older irish ones and they seem to have the right gusto. After years of stagnant outlook -people who deserve to be fired have been. Regarding the manufacturing dept. , Due to bad resource management and terrible hiring regimes (I.E the 2023 drive to replace the young energetic staff with incompetent, technologically & scientifically illiterate older people for less money) change in manufacturing has been glacial and thwarted. Adversarial mindset of supporting depts means no real change has occurred in years which drives high MFG staff turnover. Would not recommend the MFG dept, other dept possibly. 5 year outlook will not be good if a keytruda replacement is not found